pixatimod,vidutolimod,nivolumab
bms,checkmate pharmaceuticals
['nivo', 'award']
diwakar davar, md presents promising data at #sitc22 on a phase 2 study supported by a mrf breakthrough consortium team award evaluating pathological, clinical &amp; immunological activities of neoadjuvant vidu/nivo in high-risk stage 3 resectable melanoma. 